
Slipam15 mg
General Pharmaceuticals Ltd.
Flurazepam is indicated for the short-term treatment (generally 7 to 10 days, up to a maximum of 2-4 weeks) of insomnia characterized by difficulty falling asleep, frequent nighttime awakenings and more.
Flurazepam is indicated for the short-term treatment (generally 7 to 10 days, up to a maximum of 2-4 weeks) of insomnia characterized by difficulty falling asleep, frequent nighttime awakenings, and/or early morning awakening.
Flurazepam does not treat the underlying cause of insomnia and provides only symptomatic relief.
| Population/Indication | Recommended Dose |
|---|---|
| Adults (short-term insomnia) | 15 mg to 30 mg orally at bedtime |
| Elderly or debilitated patients | 15 mg orally at bedtime initially, to reduce risk of oversedation, dizziness, and falls |
| Pediatric patients | Not recommended; safety and efficacy not established in patients under 15 years of age |
| Hepatic impairment | Use lowest effective dose with caution; clearance of active metabolite is prolonged |
| Renal impairment | Use with caution; dose reduction may be needed given prolonged drug/metabolite clearance |
Take Flurazepam by mouth immediately before going to bed, as it has a rapid onset of action. Do not take Flurazepam unless you are able to get a full night's sleep (at least 7-8 hours) before you need to be active again, due to the risk of next-day drowsiness.
Flurazepam should be used for the shortest duration possible. Do not increase the dose or frequency on your own. Do not stop taking Flurazepam abruptly after prolonged use; a physician-guided gradual taper is recommended to reduce the risk of withdrawal symptoms, including seizures.
Flurazepam is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.